keyword
https://read.qxmd.com/read/30896264/qtc-prolongation-and-torsade-de-pointes-induced-by-extreme-eperisone-overdose
#21
LETTER
Yoshiyuki Haga, Yoshito Kamijo, Tomohiro Yoshizawa, Tomoki Hanazawa, Naoto Yokoyama, Tohru Kishino
No abstract text is available yet for this article.
January 2020: Clinical Toxicology
https://read.qxmd.com/read/30661315/eperisone-induced-anaphylaxis-pharmacovigilance-data-and-results-of-allergy-testing
#22
JOURNAL ARTICLE
Kyung Hee Park, Sang Chul Lee, Ji Eun Yuk, Sung Ryeol Kim, Jae Hyun Lee, Jung Won Park
PURPOSE: Eperisone is an oral muscle relaxant used in musculoskeletal disorders causing muscle spasm and pain. For more effective pain control, eperisone is usually prescribed together with nonsteroidal anti-inflammatory drugs (NSAIDs). As such, eperisone may have been overlooked as the cause of anaphylaxis compared with NSAIDs. This study aimed to analyze the adverse drug reaction (ADR) reported in Korea and suggest an appropriate diagnostic approach for eperisone-induced anaphylaxis...
March 2019: Allergy, Asthma & Immunology Research
https://read.qxmd.com/read/30415650/pharmacokinetic-and-bioequivalence-study-of%C3%A2-sugar-coated-and-film-coated-eperisone-tablets-in-healthy-subjects-a-randomized-open-label-three-way-reference-replicated-crossover-study%C3%A2
#23
JOURNAL ARTICLE
Hyun-Ju Lee, Eun-Sol Ha, Yoonseo Lee, Dae-Chul Ha, Youn-Woong Choi, In-Hwan Baek, Min-Soo Kim
OBJECTIVE: Eperisone hydrochloride is used in the treatment of musculoskeletal disorders as a muscle relaxant via blocking of calcium channels. In this study, we aimed to investigate the within-subject variability (CVwR ) of reference eperisone formulation for highly-variable drugs and to perform bioequivalence study of two oral formulations (sugar- and film-coated tablets) of eperisone hydrochloride 50 mg in healthy subjects by reference-replicated crossover study. MATERIALS AND METHODS: 36 healthy Korean male subjects were recruited, and 33 subjects completed the study...
January 2019: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/30140092/study-design-of-a-phase-ii-clinical-trial-to-assess-the-efficacy-and-safety-of-eperisone-in-japanese-type-2-diabetes-patients-with-risk-and-non-risk-alleles-of-cdkal1
#24
JOURNAL ARTICLE
Kourin Sakakida, Fan-Yan Wei, Takafumi Senokuchi, Seiya Shimoda, Tatsuyuki Kakuma, Eiichi Araki, Kazuhito Tomizawa
Genetic variation in Cdk5 Regulatory Associated Protein 1-Like 1 (CDKAL1) is associated with the development of type 2 diabetes (T2D). Dysfunction of CDKAL1 impairs the translation of proinsulin, which leads to glucose intolerance. Eperisone, an antispasmodic agent, has been shown to ameliorate glucose intolerance in Cdkal1-deficient mice. We have launched a phase II clinical study to investigate the potential anti-diabetic effect of eperisone in T2D patients carrying risk or non-risk alleles of CDKAL1. The primary endpoint is the change of hemoglobin A1c (HbA1c) levels...
August 2018: Acta Medica Okayama
https://read.qxmd.com/read/28458436/response-to-eperisone-in-patients-of-therapy-resistant-dissociative-convulsions-a-report-of-two-cases
#25
JOURNAL ARTICLE
Vijendra Nath Jha, Pramod Kumar Singh
Dissociative convulsions or pseudoseizures are a difficult to treat common psychiatric condition. In a subset of these patients, the chief complaint is clenching of teeth with apparent nonresponsiveness alone. Neither drugs nor psychotherapeutic interventions have been found to be of much help in its management. Report of two such subsets of cases is presented, in which patients with dissociative convulsions showed sudden, dramatic, and sustained good response to the addition of a muscle relaxant eperisone.
January 2017: Indian Journal of Pharmacology
https://read.qxmd.com/read/28380300/biophysical-study-on-the-interaction-between-eperisone-hydrochloride-and-human-serum-albumin-using-spectroscopic-calorimetric-and-molecular-docking-analyses
#26
JOURNAL ARTICLE
Gulam Rabbani, Mohammad Hassan Baig, Eun Ju Lee, Won-Kyung Cho, Jin Yeul Ma, Inho Choi
Eperisone hydrochloride (EH) is widely used as a muscle relaxant for patients with muscular contracture, low back pain, or spasticity. Human serum albumin (HSA) is a highly soluble negatively charged, endogenous and abundant plasma protein ascribed with the ligand binding and transport properties. The current study was undertaken to explore the interaction between EH and the serum transport protein, HSA. Study of the interaction between HSA and EH was carried by UV-vis, fluorescence quenching, circular dichroism (CD), Fourier transform infrared (FTIR) spectroscopy, Förster's resonance energy transfer, isothermal titration calorimetry and differential scanning calorimetry...
May 1, 2017: Molecular Pharmaceutics
https://read.qxmd.com/read/27989618/pharmacokinetic-interactions-between-pelubiprofen-and-eperisone-hydrochloride-a-randomized-open-label-crossover-study-of-healthy-korean-men
#27
RANDOMIZED CONTROLLED TRIAL
Ju-Hee Ryu, Joo-Il Kim, Hyung Son Kim, Gyu-Jeong Noh, Kyung-Tae Lee, Eun Kyoung Chung
PURPOSE: Pelubiprofen is a novel nonsteroidal anti-inflammatory, analgesic, and antipyretic drug with at least similar efficacy and better tolerability compared with other nonsteroidal anti-inflammatory, analgesic, and antipyretic drugs such as naproxen and aceclofenac. Eperisone hydrochloride is a centrally acting muscle relaxant that performs by blocking calcium channels. The combined use of pelubiprofen and eperisone hydrochloride is increasingly anticipated to promote the clinical effectiveness of pelubiprofen in relieving musculoskeletal symptoms of osteoarthritis, rheumatoid arthritis, and low back pain...
January 2017: Clinical Therapeutics
https://read.qxmd.com/read/27721553/eperisone-hydrochloride-induced-maculopapular-rash
#28
JOURNAL ARTICLE
Namrata Balaraddiyavar, Aruna Bhushan, Basavaraj C Kotinatot, Gouramma Huggi
Here, we report a case of a 30-year-old male who was prescribed eperisone hydrochloride for body pain and loose stools after which he developed severe maculopapular rash. Eperisone hydrochloride is an analgesic and antispastic drug used for spastic diseases such as spastic paralysis in cerebrovascular diseases, cervical spondylosis, and periarthritis. The drug is marketed in most of the Asian countries including India, but it is not licensed. Studies show the history of hypersensitivity in other countries, but this is the first reported case in India...
September 2016: Indian Journal of Pharmacology
https://read.qxmd.com/read/27371896/clinical-efficacy-and-safety-of-eperisone-for-low-back-pain-a-systematic-literature-review
#29
REVIEW
Sachin Bavage, Sharanbasappa Durg, Shoukath Ali Kareem, Shivsharan B Dhadde
Eperisone, an analgesic and centrally acting muscle relaxant has been in use for the treatment of low back pain (LBP). The present systematic review evaluates the efficacy and safety of eperisone in patients with LBP. Cochrane Back and Neck (CBN) Group and Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines were adopted to perform this systematic review. For risk of bias assessment CBN Group and Moga tools were used. Seven (5 randomized controlled trials [RCTs] and 2 uncontrolled studies) studies involving 801 participants were included...
October 2016: Pharmacological Reports: PR
https://read.qxmd.com/read/27363396/shakuyaku-kanzo-to-shao-yao-gan-cao-tang-as-treatment-of-painful-muscle-cramps-in-patients-with-lumbar-spinal-stenosis-and-its-minimum-effective-dose
#30
RANDOMIZED CONTROLLED TRIAL
Yumiko Takao, Yutaka Takaoka, Aki Sugano, Hitoaki Sato, Yasushi Motoyama, Mika Ohta, Takashi Nishimoto, Satoshi Mizobuchi
Shakuyaku-kanzo-to (Shao-Yao-Gan-Cao-Tang) is a Kampo medicine, which is known to be effective against muscle cramps as well as crampy pain in the gastrointestinal smooth muscle and skeletal muscle. However, glycyrrhizin in this medicine also causes adverse drug reactions such as hypokalemia, hypertension, and edema. We analyzed the therapeutic efficacy of Shakuyaku-kanzo-to for painful muscle cramps associated with lumbar spinal stenosis and clarified its minimum effective dose. 58 patients with lumbar spinal stenosis and painful muscle cramps were included...
April 4, 2015: Kobe Journal of Medical Sciences
https://read.qxmd.com/read/26255473/-case-control-study-on-spinal-leveraging-manipulation-and-medicine-for-the-treatment-of-degenerative-scoliosis
#31
RANDOMIZED CONTROLLED TRIAL
Gang Tian, Mao-rong Shen, Wei-guo Jiang, Fu-rong Xie, Wen-wu Wei
OBJECTIVE: To compare clinical effects of spinal leveraging manipulation and medicine for the treatment of degenerative scoliosis in pain and function. METHODS: From July 2010 to June 2013, 38 patients with degenerative scoliosis were randomly divided into spinal leveraging manipulation group and medicine group by coin tossing. In manipulation group, there were 9 males and 11 females aged from 58 to 74 years old with an average of (66.63±7.73), the courses of diseases ranged from 3 to 8 months with an average of (5...
June 2015: Zhongguo Gu Shang, China Journal of Orthopaedics and Traumatology
https://read.qxmd.com/read/25704771/simultaneous-determination-of-eperisone-hydrochloride-and-paracetamol-in-mouse-plasma-by-high-performance-liquid-chromatography-photodiode-array-detector
#32
JOURNAL ARTICLE
Marcello Locatelli, Roberta Cifelli, Cristina Di Legge, Renato Carmine Barbacane, Nicola Costa, Massimo Fresta, Christian Celia, Carlo Capolupo, Luisa Di Marzio
This paper reports the validation of a quantitative high performance liquid chromatography-photodiode array (HPLC-PDA) method for the simultaneous analysis, in mouse plasma, of eperisone hydrochloride and paracetamol by protein precipitation using zinc sulphate-methanol-acetonitrile. The analytes were resolved on a Gemini C18 column (4.6 mm × 250 mm; 5 μm particle size) using a gradient elution mode with a run time of 15 min, comprising re-equilibration, at 60°C (± 1°C). The method was validated over the concentration range from 0...
April 3, 2015: Journal of Chromatography. A
https://read.qxmd.com/read/25632432/rapid-simultaneous-determination-of-eperisone-tolperisone-and-tizanidine-in-human-serum-by-using-a-monospin%C3%A2-c18-extraction-column-and-liquid-chromatography-tandem-mass-spectrometry
#33
JOURNAL ARTICLE
Naoya Miura, Takeshi Saito, Takayuki Taira, Takeshi Yamagiwa, Sein Morita, Sadaki Inokuchi
A method was developed for rapid toxicological analysis of eperisone, tolperisone, and tizanidine in human serum using a MonoSpin® C18 extraction column and LC/MS/MS. The method was validated for LOD, linearity, precision, and extraction recovery. This method was rapid with an LOD of 0.5 ng/mL, linearity range 1-500.0 ng/mL (r2 = 0.999), and RSD value below 14.6%. Extraction recovery from the sample was greater than 98.6, 98.8, and 88.5% for eperisone, tolperisone, and tizanidine, respectively. Results showed that combination of the MonoSpin C18 extraction column and LC/MS/MS is a simple and rapid method for the analysis of these three analytes, and a method is described for simultaneous quantitative determination of the analytes in human serum by LC/MSIMS...
November 2014: Journal of AOAC International
https://read.qxmd.com/read/24942957/systematic-review-the-treatment-of-muscle-cramps-in-patients-with-cirrhosis
#34
REVIEW
H Vidot, S Carey, M Allman-Farinelli, N Shackel
BACKGROUND: Up to 88% of patients with hepatic cirrhosis experience painful muscle cramps resulting in sleep deprivation and impaired quality of life. Management is often based on poor evidence with varying degrees of success in controlling the frequency and severity of muscle cramps in this group. AIM: To review systematically the treatment options for muscle cramps in cirrhosis. METHODS: A systematic review of the relevant databases to identify treatments for muscle cramps in patients with hepatic cirrhosis was performed...
August 2014: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/24919119/sling-exercise-for-chronic-low-back-pain-a-systematic-review-and-meta-analysis
#35
REVIEW
Yu-Shan Yue, Xu-Dong Wang, Bin Xie, Zhong-Han Li, Bing-Lin Chen, Xue-Qiang Wang, Yi Zhu
BACKGROUND: Trials on sling exercise (SE), commonly performed to manage chronic low back pain (LBP), yield conflicting results. This study aimed to review the effects of SE on chronic LBP. METHODS: The randomized controlled trials comparing SE with other treatments or no treatment, published up to August 2013, were identified by electronic searches. Primary outcomes were pain, function, and return to work. The weighted mean difference (WMD) and 95% confidence interval (CI) were calculated, using a random-effects model...
2014: PloS One
https://read.qxmd.com/read/24312876/development-and-validation-of-uv-visible-spectrophotometric-method-for-simultaneous-determination-of-eperisone-and-paracetamol-in-solid-dosage-form
#36
JOURNAL ARTICLE
Shantaram Gajanan Khanage, Popat Baban Mohite, Sandeep Jadhav
PURPOSE: Eperisone Hydrochloride (EPE) is a potent new generation antispasmodic drug which is used in the treatment of moderate to severe pain in combination with Paracetamol (PAR). Both drugs are available in tablet dosage form in combination with a dose of 50 mg for EPE and 325 mg PAR respectively. METHODS: The method is based upon Q-absorption ratio method for the simultaneous determination of the EPE and PAR. Absorption ratio method is used for the ratio of the absorption at two selected wavelength one of which is the iso-absorptive point and other being the λmax of one of the two components...
2013: Advanced Pharmaceutical Bulletin
https://read.qxmd.com/read/24194981/randomized-controlled-trial-of-etodolac-versus-combination-of-etodolac-and-eperisone-in-patients-of-knee-osteoarthritis
#37
JOURNAL ARTICLE
Navjot Kaur, Harinder Singh, Avinash Chander Gupta
Objective. To compare the efficacy and tolerability of etodolac versus etodolac in combination with eperisone in patients of Osteoarthritis knee. Patients and Methods. A prospective, randomized, open label, parallel group, comparative study was conducted in 60 patients of knee OA over a period of 2 months. Thirty patients received etodolac 600 mg once daily and 30 patients received eperisone 50 mg thrice daily in addition to etodolac 600 mg once daily for 8 weeks. Efficacy assessment was done on the basis of improvement in mean scores of spontaneous pain on Visual analog scale (VAS), pain on movement, functional capacity, joint tenderness, swelling, erythema on Likert scale, and patient's overall arthritic condition on a five-point investigator scale at the end of study period as compared with the baseline scores...
2013: Pain Research and Treatment
https://read.qxmd.com/read/24155805/pharmacological-interventions-including-medical-injections-for-neck-pain-an-overview-as-part-of-the-icon-project
#38
JOURNAL ARTICLE
Paul M Peloso, Mahweesh Khan, Anita R Gross, Lisa Carlesso, Lina Santaguida, Janet Lowcock, Joy C Macdermid, Dave Walton, Charlie H Goldsmith, Pierre Langevin, Qiyun Shi
OBJECTIVES: To conduct an overview (review-of-reviews) on pharmacological interventions for neck pain. SEARCH STRATEGY: Computerized databases and grey literature were searched from 2006 to 2012. SELECTION CRITERIA: Systematic reviews of randomized controlled trials (RCT) in adults with acute to chronic neck pain reporting effects of pharmacological interventions including injections on pain, function/disability, global perceived effect, quality of life and patient satisfaction...
2013: Open Orthopaedics Journal
https://read.qxmd.com/read/24135462/serum-concentration-of-eperisone-hydrochloride-correlates-with-qt-interval
#39
JOURNAL ARTICLE
Takeshi Yamagiwa, Seiji Morita, Mari Amino, Naoya Miura, Takeshi Saito, Sadaki Inokuchi
BACKGROUND: Eperisone hydrochloride is a centrally acting muscle relaxant prescribed for muscle stiffness that acts by depressing the activities of α and γ efferent neurons in the spinal cord and supraspinal structures. Although a case of eperisone-induced severe QT prolongation had been reported, the relationship between serum eperisone concentration and QT interval remains obscure. OBJECTIVE: The aim of this study was to investigate the relationship between serum eperisone concentration and QT interval...
January 2014: American Journal of Emergency Medicine
https://read.qxmd.com/read/24050970/pharmacokinetic-interactions-between-eperisone-hydrochloride-and-aceclofenac-a-randomized-open-label-crossover-study-of-healthy-korean-men
#40
RANDOMIZED CONTROLLED TRIAL
Mi Jo Kim, Hyeong-Seok Lim, Yook-Hwan Noh, Yo Han Kim, Hee Youn Choi, Kyung-Mi Park, Sei-Eun Kim, Kyun-Seop Bae
BACKGROUND: Eperisone hydrochloride, a centrally acting muscle relaxant, is a calcium antagonist that causes vasodilation and antispastic actions. Aceclofenac, an anti-inflammatory analgesic and antipyretic drug, has similar efficacy and improved gastrointestinal tolerance compared with other nonsteroidal anti-inflammatory drugs, such as diclofenac. Although eperisone hydrochloride and aceclofenac are frequently coadministered, no published studies have reported on the pharmacokinetic interactions between these 2 drugs...
October 2013: Clinical Therapeutics
keyword
keyword
34017
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.